Cannabis for peripheral neuropathy: The good, the bad, and the unknown is organized by Cleveland Clinic Center for Continuing Education and will be held from Dec 01, 2018 - Nov 30, 2019. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.
Directed to practitioners in pain management, neurology, palliative medicine, endocrinology, psychiatry/psychology, and geriatrics.
Even where it is legal, doctors should recommend it only after careful consideration.
Readers will assess the possible benefits and risks of cannabis treatment for patients with peripheral neuropathy.